BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22487301)

  • 1. Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses.
    Nang NT; Song BM; Kang YM; Kim HM; Kim HS; Seo SH
    Influenza Other Respir Viruses; 2013 Mar; 7(2):120-31. PubMed ID: 22487301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
    Isakova-Sivak I; Chen LM; Bourgeois M; Matsuoka Y; Voeten JT; Heldens JG; van den Bosch H; Klimov A; Rudenko L; Cox NJ; Donis RO
    Clin Vaccine Immunol; 2014 May; 21(5):722-31. PubMed ID: 24648485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
    Ge J; Deng G; Wen Z; Tian G; Wang Y; Shi J; Wang X; Li Y; Hu S; Jiang Y; Yang C; Yu K; Bu Z; Chen H
    J Virol; 2007 Jan; 81(1):150-8. PubMed ID: 17050610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection.
    Tumpey TM; Renshaw M; Clements JD; Katz JM
    J Virol; 2001 Jun; 75(11):5141-50. PubMed ID: 11333895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets.
    Bodewes R; Kreijtz JH; van Amerongen G; Geelhoed-Mieras MM; Verburgh RJ; Heldens JG; Bedwell J; van den Brand JM; Kuiken T; van Baalen CA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2010 Aug; 84(16):7943-52. PubMed ID: 20519384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.
    Karron RA; Talaat K; Luke C; Callahan K; Thumar B; Dilorenzo S; McAuliffe J; Schappell E; Suguitan A; Mills K; Chen G; Lamirande E; Coelingh K; Jin H; Murphy BR; Kemble G; Subbarao K
    Vaccine; 2009 Aug; 27(36):4953-60. PubMed ID: 19540952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.
    Tretyakova I; Hidajat R; Hamilton G; Horn N; Nickols B; Prather RO; Tumpey TM; Pushko P
    Virology; 2016 Jan; 487():163-71. PubMed ID: 26529299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of four novel H5N6 avian influenza viruses with the internal genes from H5N1 and H9N2 viruses and experimental challenge of chickens vaccinated with current commercially available H5 vaccines.
    Peng C; Zhao P; Chu J; Zhu J; Li Q; Zhao H; Li Y; Xin L; Yang X; Xie S; Zhu C; Qi W; Xu G; Li J
    Transbound Emerg Dis; 2022 May; 69(3):1438-1448. PubMed ID: 33872465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.
    Zheng D; Yi Y; Chen Z
    Viruses; 2012 Dec; 4(12):3589-605. PubMed ID: 23223214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    Ghorbani A; Abundo MC; Ji H; Taylor KJM; Ngunjiri JM; Lee CW
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIV polyantigen epitope expressed by recombinant baculovirus induces a systemic immune response in chicken and mouse models.
    Yu L; Pan J; Cao G; Jiang M; Zhang Y; Zhu M; Liang Z; Zhang X; Hu X; Xue R; Gong C
    Virol J; 2020 Aug; 17(1):121. PubMed ID: 32758272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infection.
    O'Brien KB; Schultz-Cherry S; Knoll LJ
    J Virol; 2011 Sep; 85(17):8680-8. PubMed ID: 21734055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of Chickens against H9N2 Avian Influenza Isolates with a Live Vector Vaccine Expressing Influenza Hemagglutinin Gene Derived from Y280 Avian Influenza Virus.
    Zhang JF; Kim SW; Shang K; Park JY; Choi YR; Jang HK; Wei B; Kang M; Cha SY
    Animals (Basel); 2024 Mar; 14(6):. PubMed ID: 38539970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of key factors correlating with H5N1 avian influenza virus driven inflammatory lung injury of chicken identified by single-cell analysis.
    Dai M; Zhu S; An Z; You B; Li Z; Yao Y; Nair V; Liao M
    PLoS Pathog; 2023 Oct; 19(10):e1011685. PubMed ID: 37819993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of combined trivalent inactivated ISA 71 oil adjuvant vaccine against avian influenza virus subtypes (H9N2 and H5N1) and Newcastle disease virus.
    Ali ZM; Hassan MAEM; Hussein HA; Ahmed BM; Sanousi AAEE
    Vet World; 2017 Oct; 10(10):1212-1220. PubMed ID: 29184367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhance immune response to H9 AIV DNA vaccine based on polygene expression and DGL nanoparticle encapsulation.
    Xu S; Yu L; Teng Q; Li X; Jin Z; Qu Y; Li J; Zhang Q; Li Z; Zhao K
    Poult Sci; 2023 Oct; 102(10):102925. PubMed ID: 37542938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population.
    Sanz I; Rojo S; Tamames S; Eiros JM; Ortiz de Lejarazu R
    Vaccines (Basel); 2017 Jul; 5(3):. PubMed ID: 28714923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference viruses for seasonal and pandemic influenza vaccine preparation.
    Wood JS; Robertson JS
    Influenza Other Respir Viruses; 2007 Jan; 1(1):5-9. PubMed ID: 19459278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse Genetics Approaches for the Development of Influenza Vaccines.
    Nogales A; Martínez-Sobrido L
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SERS-based immunomagnetic bead for rapid detection of H5N1 influenza virus.
    Wang X; Li S; Qu H; Hao L; Shao T; Wang K; Xia Z; Li Z; Li Q
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13114. PubMed ID: 36909299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.